中医药治疗症状性颅内动脉粥样硬化性狭窄研究进展

Progress in the Study of Chinese Medicine for Symptomatic Intracranial Atherosclerotic Stenosis

症状性颅内动脉粥样硬化性狭窄是临床中导致缺血性脑血管疾病发生最常见的原因之一,颅内动脉狭窄的存在使患者脑血管缺血事件复发率明显增高,严重影响患者的预后,降低了患者生活质量,增加了社会负担。西医目前以抗血小板聚集、调脂稳斑及血管内治疗为主,但疗效欠佳且缺血事件复发率较高。中医药从整体观念出发,讲求辨证论治,近年来对症状性颅内动脉狭窄的治疗显示出一定优势。本文就近10年来中医药治疗症状性颅内动脉狭窄相关研究做一综述,以期为临床治疗提供参考。

Symptomatic intracranial atherosclerotic stenosis is one of the most common causes of ischemic cerebrovascular disease in clinical practice. The presence of intracranial arterial stenosis significantly increases the recurrence rate of cerebrovascular ischemic events, seriously affects the prognosis of patients, reduces their quality of life, and increases the social burden. Western medicine currently focuses on antiplatelet aggregation, stabilizing plaques through lipid regulation, and endovascular treatment, but the therapeutic effect is unsatisfactory and the recurrence rate of ischemic events is high. Traditional Chinese Medicine (TCM) takes a holistic approach and emphasizes individualized treatment based on syndrome differentiation. In recent years, TCM has shown certain advantages in the treatment of symptomatic intracranial arterial stenosis. This article provides a review of the relevant research on TCM treatment of symptomatic intracranial arterial stenosis in the past decade, with the aim of providing reference for clinical treatment.